Deadline: January 13, 2023
The Accelerating Health Business More, is a targeted structured business growth program for social entrepreneurs with innovative solutions in the health sector. This program offers two phases of engagement.
Phase 1, called “Pilot Phase”, runs for 12 months and focuses on supporting entrepreneurs to:
- a) identify strategic challenges and/or opportunities related to the growth, sustainability and impact of the social enterprise
- b) jointly create and test relevant solutions.
Phase 2, called “Scale-up phase” also runs for 12 months and focuses on supporting participants to scale up successful solutions from the first phase of engagement. In both phases, participating entrepreneurs are provided with access to technical support from employees of Boehringer Ingelheim, strategic network, financial resourcesand a platform for collaborationlearn and engage with fellow social entrepreneurs and other ecosystem actors.
The accelerator is broadly focused on supporting social entrepreneurs with innovative solutions aimed at promoting access to healthcare in Sub-Saharan Africa. The solution can be either in the field of animal or human health. The specific countries we are currently selecting participants from are Kenya, Uganda, Rwanda, Nigeria, and Ghana.
You should apply for the program if you have an innovative human or animal health solution that fits the description provided above and if you meet the criteria below.
- Legal institutions: Companies limited by guarantee, Limited liability companies, NGOs
- well: At least three years of operation
- sector: Related to human or animal health.
- Country of operation: Ghana, Nigeria, Kenya, Uganda, and Rwanda.
- Income: At least USD 100K in annual sales revenue.
- IMPACT: Evidence of social impact with clear impact metrics
The program offers participants multiple opportunities for growth and professional development in their entrepreneurial journey. Includes in-person and online workshops and seminars on topics related to operations, system change, replication and transfer, social finance, and more.
Participants have access to experienced employees at Boehringer Ingelheim who volunteer their time to provide hands-on technical support across a variety of professional disciplines. Participation with BI employees can take place virtually or in person through the Executive in Residence program in which experienced executives are placed in a social entrepreneur organization between 2-4 weeks to work on specific aspects of the project.
Accelerator participants become part of an ever-growing and closely-knit community of ecosystem actors including impact investors, foundations, philanthropists, government agencies, corporate executives, social entrepreneurs, experts and multinational healthcare companies all committed to improving access to healthcare for humans and animals across Africa. .
financial access support and Investors
The program provides each participant with a grant of 50k Euros for the implementation of the pilot, with the possibility of additional scale up funds at the end of the successful pilot. Participants also receive expert-led investment readiness training and support before and after the program to facilitate access to third-party investors.
Where there is a timely and strategic fit between Boehringer Ingelheim and an accelerator participant, there is the potential for a strategic business collaboration to be formed with the promise of significant long-term benefits for both organizations.
|Application submission||November 14, 2022 – January 13, 2023|
|One-on-one interviews||January 14, 2023 – February 20, 2023|
|Due diligence and site visits||1 February 2023 – 28 February 2023|
|Panel interview||March 15, 2023|
|March 17, 2023|
For more information: